✦ LIBER ✦

Biomarkers of drugs targeting HER-family signalling in cancer

✍ Scribed by Montemurro, Filippo; Scaltriti, Maurizio

Book ID: 121834085
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 632 KB
Volume: 232
Category: Article
ISSN: 0022-3417
DOI: 10.1002/path.4269

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biological significance and targeting of

Biological significance and targeting of HER family members in cancer

✍ Helmout Modjtahedi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Drugs for HER-2-positive Breast Cancer V

Drugs for HER-2-positive Breast Cancer Volume 7 || The EGFR/ErbB Family in Breast Cancer: From Signalling to Therapy

✍ Sibilia, Maria; Zielinski, Christoph C.; Bartsch, Rupert; Grunt, Thomas W. 📂 Article 📅 2010 🏛 Springer Basel 🌐 German ⚖ 425 KB

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory

Targeting tissue-specific signalling in

Targeting tissue-specific signalling in cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Investigational therapies targeting the

Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers

✍ Desai, Monica Dandona; Saroya, Bikramajit Singh; Lockhart, Albert Craig 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 421 KB

The role of HER2 in cancer therapy and t

The role of HER2 in cancer therapy and targeted drug delivery

✍ Wanyi Tai; Rubi Mahato; Kun Cheng 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 920 KB

The HER3/ErbB3 receptor: A promising tar

The HER3/ErbB3 receptor: A promising target in cancer drug therapy

✍ Desbois-Mouthon, C. 📂 Article 📅 2010 🏛 Masson Editeur 🌐 French ⚖ 333 KB